Literature DB >> 23363314

Cancer incidence and survival in adolescents and young adults in France, 2000-2008.

Emmanuel Desandes1, Brigitte Lacour, Aurélien Belot, Florence Molinie, Patricia Delafosse, Brigitte Tretarre, Michel Velten, Erik-André Sauleau, Anne-Sophie Woronoff, Anne-Valérie Guizard, Olivier Ganry, Simona Bara, Pascale Grosclaude, Xavier Troussard, Véronique Bouvier, Laurence Brugieres, Jacqueline Clavel.   

Abstract

This study aimed to describe cancer incidence (2000-2008) and survival (2000-2004) in France in adolescents and young adults (AYA). All cases of cancer diagnosed in 15-24 years, recorded by all French population-based registries (14% of the French population), over the 2000-2008 period, were included. Incidence change over time was described with the conventional annual percentage change (cAPC). The survival of cases diagnosed (2000-2004) was estimated using Kaplan-Meier method. A total of 1022 in adolescents and 1396 in young adults were diagnosed. Overall incidence rates were 219.4/10(6) in 15-19 year olds and 293.1/10(6) in 20-24 year olds. The most frequently diagnosed cancers in male AYA were malignant gonadal germ-cell tumors and Hodgkin's disease, and were melanoma, thyroid carcinoma, and Hodgkin's disease in females. The age-standardized rates appeared stable over time in AYA, with a cAPC of +2.0% (P = 0.68). The 5-year overall survival for all cancers was different between genders and age groups, with 78.8% (95%CI: 75.6-82.0) for males and 85.2% (95%CI: 82.2-88.1) for females (P = 0.01), and 78.5% (95%CI: 75.0-82.1) in 15-19 year olds and 84.3% (95% CI: 81.6-87.0) in 20-24 year olds (P = 0.02). Noteworthy, the frequency and the distribution of tumor types in AYA are unique and different from the observed at any other age group. Survival in French AYA has improved over time. Epidemiological data might reflect major trends in the risk factors and preventive interventions. Thus, further research into etiology of cancers affecting AYA should become key priorities for cancer control among AYA.

Entities:  

Mesh:

Year:  2013        PMID: 23363314     DOI: 10.3109/08880018.2012.762569

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  5 in total

1.  Familial predisposition to TP53/complex karyotype MDS and leukemia in DNA repair-deficient xeroderma pigmentosum.

Authors:  Alain Sarasin; Samuel Quentin; Nathalie Droin; Mourad Sahbatou; Véronique Saada; Nathalie Auger; Yannick Boursin; Philippe Dessen; Anna Raimbault; Vahid Asnafi; Jean-Luc Schmutz; Alain Taïeb; Carlos F M Menck; Filippo Rosselli; Laurianne Drieu La Rochelle; Caroline Robert; Flore Sicre de Fontbrune; Marie Sébert; Thierry Leblanc; Patricia Kannouche; Stéphane De Botton; Eric Solary; Jean Soulier
Journal:  Blood       Date:  2019-03-26       Impact factor: 22.113

2.  Cancer incidence and survival among adolescents and young adults in Korea.

Authors:  Eun-Kyeong Moon; Hyeon Jin Park; Chang-Mo Oh; Kyu-Won Jung; Hee Young Shin; Byung Kiu Park; Young-Joo Won
Journal:  PLoS One       Date:  2014-05-01       Impact factor: 3.240

3.  ICG-001, an Inhibitor of the β-Catenin and cAMP Response Element-Binding Protein Dependent Gene Transcription, Decreases Proliferation but Enhances Migration of Osteosarcoma Cells.

Authors:  Geoffroy Danieau; Sarah Morice; Sarah Renault; Régis Brion; Kevin Biteau; Jérôme Amiaud; Marie Cadé; Dominique Heymann; Frédéric Lézot; Franck Verrecchia; Françoise Rédini; Bénédicte Brounais-Le Royer
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-01

4.  Trends in survival for teenagers and young adults with cancer in the UK 1992-2006.

Authors:  C O'Hara; A Moran; J S Whelan; R E Hough; C A Stiller; M C G Stevens; D P Stark; R G Feltbower; M G McCabe
Journal:  Eur J Cancer       Date:  2015-07-25       Impact factor: 9.162

5.  Cardiac Mortality Among 200 000 Five-Year Survivors of Cancer Diagnosed at 15 to 39 Years of Age: The Teenage and Young Adult Cancer Survivor Study.

Authors:  Katherine E Henson; Raoul C Reulen; David L Winter; Chloe J Bright; Miranda M Fidler; Clare Frobisher; Joyeeta Guha; Kwok F Wong; Julie Kelly; Angela B Edgar; Martin G McCabe; Jeremy Whelan; David J Cutter; Sarah C Darby; Mike M Hawkins
Journal:  Circulation       Date:  2016-11-07       Impact factor: 29.690

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.